Geometry Dash APK Hill Climb Racing APK
15.6 F
New York
Friday, January 21, 2022

Ibio Inc (NYSEAMERICAN:IBIO) Is Making Continuous Progress, But Stock Not Holding Gains

Must read

Humbl Inc (OTCMKTS:TSNPD) Bounces Back and Lands On The Radar

Over the course of the past months, Humbl Inc (OTCMKTS:TSNPD) stock has managed to record massive gains and much of that has...

Alpine 4 Technologies Ltd (OTCMKTS:ALPP) Looks to Maintain Critical Momentum

Stocks that make massive gains over a reasonable period of time cannot hope to maintain them forever. At some point, a correction...

Green Thumb Industries Inc (OTCMKTS:GTBIF) Trades Near All-Time High: What Next?

After having been in the dumps for more than a year, the cannabis sector has managed to make a remarkable comeback. Investors...

VIVO Cannabis Inc (OTCMKTS:VVCIF) Stock Turns Volatile: Uptrend in Jeopardy

Anyone watching the market knows the cannabis sector has been booming again. Since the start of the year, the cannabis sector has...

The coronavirus pandemic has been one of the biggest healthcare crises in history, and it has also had a hugely negative effect on the stock markets. The majority of stocks have declined significantly, but companies that are involved in developing coronavirus vaccines have seen their stocks soar. One such company is Ibio Inc (NYSEAMERICAN IBIO), which made a major announcement recently.

Additional News

The company revealed this morning that it had signed a Memorandum of Understanding with the influential Infectious Disease Research Institute, and the two are going to work towards taking forward the work related to the coronavirus vaccine candidate.

It is a significant piece of news since the support system provided by the (IDRI) could be crucial for iBio as it tries to develop the vaccine candidate. This was possibly recognized by investors as well, and the stock soared by as much as 26% on the back of the news.

It remains to be seen whether the stock can add to its gains through the rest of the day. It could be worthwhile for investors to keep an eye on the iBio stock. IDRI will not only support the preclinical development of the product but will also manage the clinical trials that are surely going to take place later on.

Much Needed Support

iBio will be involved in providing the much-needed support structure that is necessary to develop such a vaccine. It is going to take care of the development process and the manufacturing services that are going to be crucial. It could prove to be a strong collaboration. The Chief Executive Officer and Chairman of iBio, Tom Isett, said as much.

He said that the company is “looking forward to evaluating the novel adjuvants in IDRI’s portfolio that may deliver even greater immunostimulatory effects.” If iBio decides to include one of the adjuncts in the program from IDRI, then the MoU could be amended within 60 days.

Latest article

iQSTEL Inc (OTCMKTS:IQST) Stock Makes a Big Move: Jumps 45% In a Week

In the past week, iQSTEL Inc (OTCMKTS: IQST) has emerged as a point of focus among a large number of investors and...

HUMBL Inc (OTCMKTS:HMBL) Stock Sees Big Bounce After Recent Slump

Since the beginning of 2021, HUMBL Inc (OTCMKTS:HMBL) had been one of the major movers from among penny stocks and had come into...

Dividend Stocks to Buy Now

A classic mistake that investors make when looking for dividend stocks is to just go for the biggest dividend yield. It makes...

88 Energy Ltd (OTCMKTS:EEENF) Stock Surges 40% But Can’t Hold Gains

The oil and gas company 88 Energy Ltd (OTCMKTS:EEENF) seems to have come back on to the radars of investors over the...

Net Savings Link Inc (OTCMKTS:NSAV) Stock is Getting Pummeled Again

Nowadays there are plenty of options for investors when it comes to making investments in the cryptocurrency and...
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet. Affordable best sms verification service